OHSU Knight Cancer Institute at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
OHSU Knight Cancer Institute brings 4 presentations to ASH 2026 in New Orleans, and exhibits at Booth 2523. Its research spans systemic mastocytosis, acute myeloid leukemia and lymphoma. Work covers a KIT mutant mastocytosis model, venetoclax with cladribine and a symposium on high-risk acute myeloid leukemia.
| Organization | ASH 2026 Attendance |
|---|---|
OHSU Knight Cancer Institute Portland, OR | |
NCI-designated comprehensive cancer center at Oregon Health & Science University in Portland, for cancer research, care and education. | Booth Exhibiting at Booth 2523 Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm Symposium Fri Dec 11 11:00am–2:00pm Decoding High-Risk AML: Applying Molecular Insights to Clinical Decision-Making Using tests for isocitrate dehydrogenase and Flt3 mutations to guide targeted therapy choices in acute myeloid leukemia. Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sun Dec 13 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm |
Find decision makers at OHSU Knight Cancer Institute
Tell us what you sell and we’ll find the people at OHSU Knight Cancer Institute most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction